Email signals / 168
#168
| id | 168 |
|---|---|
| source_id | — |
| gmail_thread_id | 19e2b73bf95b335e |
| gmail_message_id | 19e2b73bf95b335e |
| email_date | 2026-05-15T00:00:00+00:00 |
| email_subject | Fwd: Valion Bio Q1 2026 results |
| email_sender | tmpearsall@aol.com |
| signal_type | general_intel |
| company_name_raw | — |
| matched_company_id | — |
| amount_usd | — |
| valuation_usd | — |
| investor_names | — |
| signal_summary | DEAL+OPERATOR: Valion Bio Q1 2026 results (public; via investorpass). Operator note: "Osparna was an investor in Tivic before it went pub... |
| source_url | — |
| confidence | medium |
| reviewed | true |
| applied_to_db | true |
| applied_at | — |
| created_at | 2026-06-04T03:21:42.461178+00:00 |
| tenant_id | 1 |
| alert_term | — |
| channel | operator_forward |
| entry_reason | — |
| first_publication_at | — |
| provenance_type | analysis |
| independence_group | — |
| reading_id | 160 |
| item_ordinal | 0 |
| category_slug | — |
| category_confidence | — |
| category_note | — |
| company_host | — |